“Teriparatide reduces fracture risk in defined osteoporosis populations.”

Supported with scope

The reviewed evidence supports this exact statement only in the situation described below.

The pivotal evidence and label support vertebral and nonvertebral fracture-risk reduction in studied high-risk populations.

What this answer is based on

This answer uses a study that assigned people to groups by chance and measured a health outcome.

Limits of this answer

Labeled osteoporosis populations at high fracture risk. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.

Topic

What a study measured about people's health, symptoms, or ability to function.